Dialysis clinic operator Fresenius Medical Care has appointed Frank Maddux, the company’s global chief medical officer, to the board. He starts his new position on 1 January
Maddux is a physician, IT entrepreneur and health care executive with more than 30 years of health care experience. He has worked for Fresenius Medical Care since 2009. Most recently he served as executive vice president for clinical & scientific affairs and chief medical officer for Fresenius Medical Care North America with responsibility for the delivery of high-quality, value-based care for the largest integrated renal care network in the US. His expertise and research interests have been focused on the quality of care for chronic kidney disease patients.
He was appointed global chief medical officer in March.
“As global chief medical officer, Frank Maddux enjoys an outstanding reputation both inside and outside of Fresenius Medical Care. With his proven medical competence and experience, which he can contribute, he will be a great addition to the company’s management board,” said chairman Stephan Sturm.
His appointment came as Fresenius exceeded Q3 revenue forecasts.
Third-quarter revenues rose 8% at Fresenius to €8.9bn (US$9.9bn) while those at Fresenius Medical Care were up 9% at €4.4bn.